ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Cadrenal Therapeutics Inc

Cadrenal Therapeutics Inc (CVKD)

15.85
0.35
(2.26%)
Closed January 05 4:00PM
14.70
-1.15
(-7.26%)
After Hours: 7:50PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
14.70
Bid
13.00
Ask
17.50
Volume
32,673
14.9912 Day's Range 15.75
5.40 52 Week Range 32.55
Market Cap
Previous Close
15.50
Open
15.26
Last Trade
4
@
14.71
Last Trade Time
Financial Volume
$ 498,364
VWAP
15.2531
Average Volume (3m)
73,661
Shares Outstanding
1,658,771
Dividend Yield
-
PE Ratio
-3.11
Earnings Per Share (EPS)
-5.04
Revenue
-
Net Profit
-8.36M

About Cadrenal Therapeutics Inc

Cadrenal Therapeutics is a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) designed to provide safer, more effective chronic anticoagulation for patients with implanted cardiac devices or rare cardiovascular conditions. Tecarfarin is expected to reduce ad... Cadrenal Therapeutics is a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) designed to provide safer, more effective chronic anticoagulation for patients with implanted cardiac devices or rare cardiovascular conditions. Tecarfarin is expected to reduce adverse events such as strokes, heart attacks, and bleeds compared to warfarin, which poses challenges due to drug interactions, kidney impairment and frequent dosing adjustments. Cadrenal is focused on evaluating tecarfarin's superiority to warfarin in patients for whom direct oral anticoagulants (DOACs) are not recommended in the treatment guidelines of leading cardiology associations. Tecarfarin has orphan drug and fast-track designations for LVAD and end-stage kidney disease patients with atrial fibrillation. Cadrenal is advancing a pivotal trial and pursuing clinical and commercial partnerships, with plans to study mechanical heart valve patients facing anticoagulation challenges. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Middletown, Delaware, USA
Founded
-
Cadrenal Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CVKD. The last closing price for Cadrenal Therapeutics was $15.50. Over the last year, Cadrenal Therapeutics shares have traded in a share price range of $ 5.40 to $ 32.55.

Cadrenal Therapeutics currently has 1,658,771 shares outstanding. The market capitalization of Cadrenal Therapeutics is $25.71 million. Cadrenal Therapeutics has a price to earnings ratio (PE ratio) of -3.11.

CVKD Latest News

Cadrenal Therapeutics Provides 2024 Year-End Company Update, Reinforcing Clinical Development Plan for Tecarfarin in LVAD and Other Rare Cardiovascular Indications

Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) today recapped its 2024 milestones and highlighted a clear path forward to develop the investigational drug tecarfarin as a superior and safer chronic...

Cadrenal Therapeutics Gears Up for the 43rd Annual J.P. Morgan Healthcare Conference Week with Event Participation and Investor/Partner Meetings

Lays out Phase 3 Clinical and Regulatory Path for Tecarfarin and Three-Year Strategic Plan Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), announced today its engagement in three key events leading...

Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook

Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook PR Newswire PONTE VEDRA, Fla., Nov. 19, 2024 Recognized as innovative biopharma developing a...

CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS

CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS PR Newswire PONTE VEDRA, Fla., Nov. 12, 2024 Leading heart failure...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.57-9.6496619545216.2716.4913.53645357315.21190944CS
40.97517.1046054980413.72491810.27744413.79932144CS
123.4330.434782608711.2719.9710.27366114.96786298CS
267.4265102.10352657.273519.975.79587810.01250449CS
525.722563.74269005858.977532.555.418731712.18102302CS
156-70.95-82.837127845985.65101.255.419187622.17126696CS
260-70.95-82.837127845985.65101.255.419187622.17126696CS

CVKD - Frequently Asked Questions (FAQ)

What is the current Cadrenal Therapeutics share price?
The current share price of Cadrenal Therapeutics is $ 14.70
How many Cadrenal Therapeutics shares are in issue?
Cadrenal Therapeutics has 1,658,771 shares in issue
What is the market cap of Cadrenal Therapeutics?
The market capitalisation of Cadrenal Therapeutics is USD 25.71M
What is the 1 year trading range for Cadrenal Therapeutics share price?
Cadrenal Therapeutics has traded in the range of $ 5.40 to $ 32.55 during the past year
What is the PE ratio of Cadrenal Therapeutics?
The price to earnings ratio of Cadrenal Therapeutics is -3.11
What is the reporting currency for Cadrenal Therapeutics?
Cadrenal Therapeutics reports financial results in USD
What is the latest annual profit for Cadrenal Therapeutics?
The latest annual profit of Cadrenal Therapeutics is USD -8.36M
What is the registered address of Cadrenal Therapeutics?
The registered address for Cadrenal Therapeutics is 651 N BROAD ST SUITE 201, NEW CASTLE, MIDDLETOWN, DELAWARE, 19709
What is the Cadrenal Therapeutics website address?
The website address for Cadrenal Therapeutics is www.cadrenal.com
Which industry sector does Cadrenal Therapeutics operate in?
Cadrenal Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FCUVFocus Universal Inc
$ 0.9499
(174.93%)
259.78M
NITON2OFF Inc
$ 2.6306
(145.85%)
350.92M
CRNCCerence Inc
$ 19.33
(143.76%)
159.55M
KITTNauticus Robotics Inc
$ 3.8249
(140.56%)
104.78M
ACONAclarion Inc
$ 0.2984
(110.14%)
305.59M
HWHHWH International Inc
$ 0.4621
(-28.80%)
7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF
$ 5.69
(-26.30%)
24.77M
RAINRain Enhancement Technologies Holdco Inc
$ 5.59
(-23.42%)
161.15k
PTLEPTL Ltd
$ 9.35
(-23.30%)
1.04M
NXUNXU Inc
$ 0.725868
(-22.78%)
7.59M
NITON2OFF Inc
$ 2.6306
(145.85%)
358.28M
TGLTreasure Global Inc
$ 0.382
(101.58%)
337.5M
ACONAclarion Inc
$ 0.2984
(110.14%)
305.64M
FCUVFocus Universal Inc
$ 0.9499
(174.93%)
260.93M
NVDANVIDIA Corporation
$ 144.47
(4.45%)
230.01M

CVKD Discussion

View Posts
Lugnut Lugnut 2 weeks ago
Watchers will become chasers
πŸ‘οΈ0
Imokhopeur Imokhopeur 2 weeks ago
This will be a blockbuster 
πŸ‘οΈ0
MahinAgency MahinAgency 1 month ago
Strong Buy 💃💃💃🫀
πŸ‘οΈ0
MahinAgency MahinAgency 1 month ago
NASDAQ: $CVKD BIG OPPORTUNITY

2025 Projected Revenue: $6.3 million, driven by potential initial commercialization of tecarfarin.

2026 Projected Revenue: $16.8 million, reflecting expected market adoption and growth?
πŸ‘οΈ0
MahinAgency MahinAgency 1 month ago
NASDAQ: $CVKD

2025 Projected Revenue: $6.3 million, driven by potential initial commercialization of tecarfarin.

2026 Projected Revenue: $16.8 million, reflecting expected market adoption and growth?
πŸ‘οΈ0
MahinAgency MahinAgency 1 month ago
NASDAQ: $CVKD BIG WAVE SOON, STRONG💪💪

2025 Projected Revenue: $6.3 million, driven by potential initial commercialization of tecarfarin.

2026 Projected Revenue: $16.8 million,reflecting expected market adoption and growth?
πŸ‘οΈ0
MahinAgency MahinAgency 1 month ago
NASDAQ: $CVKD

Hc Wainwright raises Cadrenal Therapeutics price target to $32 from $3
Buy

Innovative Drug & Partnership: Tecarfarin, developed with Abbott, targets a $2B U.S. market for blood thinners.
👍️ 1
MahinAgency MahinAgency 1 month ago
NASDAQ: $CVKD

Cadrenal Therapeutics Wins "Anticoagulation Therapy Company of the Year"

$CVKD
-Hc Wainwright raises Cadrenal Therapeutics price target $32
Buy
πŸ‘οΈ0
MahinAgency MahinAgency 1 month ago
NASDAQ: $CVKD

Cadrenal Therapeutics Named "Anticoagulation Therapy Company of the Year"

$CVKD-Hc Wainwright raises Cadrenal Therapeutics price target to $32 from $3
Buy
πŸ‘οΈ0
MahinAgency MahinAgency 1 month ago
Breaking NEWS:🚨

Cadrenal Therapeutics Wins "Anticoagulation Therapy Company of the Year"

Innovation: Tecarfarin minimizes drug interactions, improves stability, and suits patients with kidney impairment.
πŸ‘οΈ0
MahinAgency MahinAgency 2 months ago
NASDAQ: $CVKD Upcoming Catalysts: With trial results and potential FDA approval on the horizon, CVKD is positioned for substantial growth, presenting a strategic opportunity for investors in the biotech space.
πŸ‘οΈ0
MahinAgency MahinAgency 2 months ago
NASDAQ: $CVKD Targeting a $2 billion US market and addresses a critical unmet medical need in cardiovascular care during a global health crisis
πŸ‘οΈ0
MahinAgency MahinAgency 2 months ago
NASDAQ: $CVKD Cadrenal is collaborating with Abbott on Tecarfarin, a novel blood thinner targeting a $2 billion U.S. market.

Hc Wainwright raises Cadrenal Therapeutics price target to $32 from $3
πŸ‘οΈ0
Lugnut Lugnut 2 months ago
A nice steady climb
πŸ‘οΈ0
Imokhopeur Imokhopeur 3 months ago
Don’t wait
πŸ‘οΈ0
Imokhopeur Imokhopeur 3 months ago
All the makings of a very big drug with longevity to match. All IMO
πŸ‘οΈ0
Imokhopeur Imokhopeur 3 months ago
The below was reported at the September 16, 2024 update.
πŸ‘οΈ0
Imokhopeur Imokhopeur 3 months ago
β€œThe final protocol will be announced following discussions with the FDA in fall 2024”
It’s fall 2024. Y’all ready?
πŸ‘οΈ0
MRc2 MRc2 3 months ago
$CVKD~ $20.00 Target eom
πŸ‘οΈ0
TradeSmart.ai TradeSmart.ai 3 months ago
This thing finally moving huh $CVKD
πŸ‘οΈ0
stocktowatch stocktowatch 4 months ago
$CVKD BIG NEWS : New Blood Thinner Ready for Phase 3; Initiating Coverage of Cadrenal
Therapeutics, Inc
Zack Smallcap Research report - https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_09162024_CVKD_Bautz.pdf
πŸ‘οΈ0
moondogaz moondogaz 4 months ago
With all do respect...this one turned out nice...ty.
👍 1
jwrmo jwrmo 4 months ago
Anyone know when exactly this meeting with the FDA will take place?
πŸ‘οΈ0
TradeSmart.ai TradeSmart.ai 4 months ago
Excellent move, much more to come $CVKD
👍️ 1
TradeSmart.ai TradeSmart.ai 4 months ago
Heart disease $200 Billion problem and they should have a very nice niche of it with their upcoming treatment. Let’s see gimme $100
👍️ 1
jwrmo jwrmo 4 months ago
Its prime time for news and this is dropping. I say Buy.
πŸ‘οΈ0
jwrmo jwrmo 4 months ago
I dont understand why this is dropping. I am going to hold though because the price is predicted to get to 52.00.
πŸ‘οΈ0
moondogaz moondogaz 4 months ago
Volume increasing
πŸ‘οΈ0
stocktowatch stocktowatch 4 months ago
$CVKD Chart looks ready to move higher imo https://schrts.co/hfdruFjZ
πŸ‘οΈ0
stocktowatch stocktowatch 4 months ago
$CVKD Research Report must Read - https://bigstocks.com/cadrenal-therapeutics/
πŸ‘οΈ0
stocktowatch stocktowatch 4 months ago
$CVKD 1 Month bullish chart https://schrts.co/ijBMJKCK
πŸ‘οΈ0
stocktowatch stocktowatch 4 months ago
$CVKD Strong buy from #tradingview https://www.tradingview.com/symbols/NASDAQ-CVKD/technicals/
πŸ‘οΈ0
stocktowatch stocktowatch 4 months ago
$CVKD Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD Patients https://finance.yahoo.com/news/cadrenal-therapeutics-announces-upcoming-type-130000800.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via
@YahooFinance
πŸ‘οΈ0
stocktowatch stocktowatch 4 months ago
$CVKD Volume precedes price action, following trend pattern could see reversal any time any days imo!
https://schrts.co/hGXgHbiy
πŸ‘οΈ0
moondogaz moondogaz 4 months ago
Fine as wine.....
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 4 months ago
CVKD 8 BUCKS, LETS SEE 9.00
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 4 months ago
CVKD HERE COMES 8 BUCKS
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 4 months ago
CVKD...WE SEE 8 BUCKS TODAY OR TOMORROW
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 4 months ago
CVKD...8 BUCKS AROUND THE CORNER
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 5 months ago
CVKD...8 DOLLA CLOSING IN!!!
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 5 months ago
here comes 8 dolla....lmao
πŸ‘οΈ0
KISSINGER KISSINGER 5 months ago
Do not listen to this guy. Here is his last recco which is now under $2.00

TrendTrade2016

Re: None

Friday, August 02, 2024 8:34:21 AM

Post#
4
of 13
VSEE HERE COMES 7 BUCKS
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 5 months ago
CVKD 8 BUCKS COMING TO TOWN
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 5 months ago
CVKD...LETS SEE 8 DOLLA
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 5 months ago
CVKD...THERE SHE GOES
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 5 months ago
CVKD...POST SPLIT BEASTING...1 MILLY FLOT
πŸ‘οΈ0
gail gail 5 months ago
its trying to inch up now, lets ….

….

see what happens here.
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 5 months ago
DILUTE INTO NEWS
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 5 months ago
CVKD BIG NEWS
πŸ‘οΈ0
Imokhopeur Imokhopeur 7 months ago
Green time run here, partnerships and approval coming in this order imo!
👍️ 1

Your Recent History

Delayed Upgrade Clock